TRUPANION, INC. (TRUP): Results of Operations and Financial Condition
TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Trupanion Reports Second Quarter 2026 Results Authorizes Share Repurchase Program SEATTLE, WA. August 5, 2026 -- Trupanion , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended
How this was made
The 30-second read
Why it matters
Traders can reassess near-term fundamentals using the reported revenue growth, adjusted EBITDA improvement, and free cash flow increase, while also factoring in potential support from the newly authorized repurchase program and the extraordinary dividend approval.
Market read
Fresh quarterly financial metrics and a new buyback authorization are likely to drive immediate repricing and positioning ahead of the conference call.
What to watch
Buyback timing is discretionary and tied to compliance with the PNC credit facility and available cash, so the authorization may not translate into immediate share demand.
Trupanion Reports Second Quarter 2026 Results Authorizes Share Repurchase Program
Revenue, subscription revenue, adjusted EBITDA and cash flow increased from the prior-year period, while total enrolled pets declined and quarterly net income decreased.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Total revenue, second quarter 2026GAAP | $392.9 million | – | 11% |
| Subscription business revenue, second quarter 2026GAAP | $276.7 million | – | 14% |
| Subscription business revenue, three months ended June 30, 2026GAAP | $ 276,690 | – | – |
| Net income, second quarter 2026GAAP | $6.8 million | – | – |
| Basic earnings per share, second quarter 2026GAAP | $0.16 per basic share | – | – |
| Diluted earnings per share, second quarter 2026GAAP | $0.16 per diluted share | – | – |
| Adjusted EBITDA, second quarter 2026non-GAAP | $19.8 million | – | – |
| Operating cash flow, second quarter 2026GAAP | $21.0 million | – | – |
| Free cash flow, second quarter 2026non-GAAP | $19.2 million | – | – |
| Total revenue, first six months of 2026GAAP | $777.0 million | – | 12% |
| Subscription business revenue, first six months of 2026GAAP | $546.1 million | – | 15% |
| Subscription business revenue, six months ended June 30, 2026GAAP | $ 546,144 | – | – |
| Net income, first six months of 2026GAAP | $11.7 million | – | – |
| Basic earnings per share, first six months of 2026GAAP | $0.27 per basic share | – | – |
| Diluted earnings per share, first six months of 2026GAAP | $0.27 per diluted share | – | – |
| Adjusted EBITDA, first six months of 2026non-GAAP | $37.1 million | – | – |
| Operating cash flow, first six months of 2026GAAP | $35.6 million | – | – |
| Free cash flow, first six months of 2026non-GAAP | $32.9 million | – | – |
| Total enrolled pets, June 30, 2026other | 1,633,131 | – | decrease of 2% |
| Subscription enrolled pets, June 30, 2026other | 1,124,548 | – | increase of 5% |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Subscription businessSubscription enrolled pets was 1,124,548 at June 30, 2026, an increase of 5% over June 30, 2025. | $276.7 million | – | 14% |
Capital returns
- In July 2026, the New York Department of Financial Services approved an extraordinary dividend of $44 million to be paid to Trupanion by its wholly-owned subsidiary, American Pet Insurance Company.
- The Board authorized a share repurchase program to repurchase up to an aggregate of $100.0 million of outstanding common stock, with no expiration date.
What drove it
- Total revenue increased 11% compared to the second quarter of 2025.
- Subscription business revenue increased 14% compared to the second quarter of 2025.
- Subscription enrolled pets increased 5% over June 30, 2025.
- Adjusted EBITDA was $19.8 million, compared to adjusted EBITDA of $16.6 million in the second quarter of 2025.
- Operating cash flow and free cash flow increased compared to the second quarter of 2025.
Concerns
- Total enrolled pets, including pets from the other business segment, decreased 2% over June 30, 2025.
- Second-quarter net income was $6.8 million, compared to net income of $9.4 million in the second quarter of 2025.
- The actual number and timing of share repurchases depend on factors including compliance with the PNC credit facility, available cash, cash flow from operations, stock price, economic, business and market conditions, and alternative investment opportunities.
What to watch
- Whether subscription enrolled-pet growth continues while total enrolled pets, including the other business segment, remains below the prior-year level.
- Execution of the up to $100.0 million share repurchase program.
- Deployment of the $44 million extraordinary dividend approved for payment to Trupanion.
- Future trends in net income relative to adjusted EBITDA, operating cash flow and free cash flow.
Balance sheet and cash flow
- At June 30, 2026, the Company held $398.5 million in cash and short-term investments.
- An additional $3.5 million was available under its credit facility.
- Operating cash flow was $21.0 million and free cash flow was $19.2 million in the second quarter of 2026.
- Operating cash flow was $35.6 million and free cash flow was $32.9 million in the first six months of 2026.
Analysis
Trupanion reported second-quarter total revenue of $392.9 million, an increase of 11% compared to the second quarter of 2025. Subscription business revenue was $276.7 million, up 14%, exceeding the total-company growth rate. For the first six months of 2026, total revenue was $777.0 million, up 12%, while subscription business revenue was $546.1 million, up 15%.
Enrollment trends were mixed. Total enrolled pets, including pets from the other business segment, was 1,633,131 at June 30, 2026, a decrease of 2% over June 30, 2025. In contrast, subscription enrolled pets reached 1,124,548, an increase of 5%. The difference between subscription revenue and enrollment growth versus the total enrolled-pet trend is a central operating metric for the period.
Profitability and cash generation improved on several measures, but quarterly GAAP net income declined. Net income was $6.8 million, or $0.16 per basic and diluted share, compared with $9.4 million, or $0.22 per basic and diluted share, in the second quarter of 2025. Adjusted EBITDA increased to $19.8 million from $16.6 million. Operating cash flow increased to $21.0 million from $15.0 million, and free cash flow increased to $19.2 million from $12.0 million.
For the first six months, net income was $11.7 million compared with $7.9 million, and adjusted EBITDA was $37.1 million compared with $28.8 million. Operating cash flow was $35.6 million and free cash flow was $32.9 million, compared with $31.0 million and $26.1 million, respectively. The company held $398.5 million in cash and short-term investments, with an additional $3.5 million available under its credit facility.
Capital allocation was a prominent part of the release. The New York Department of Financial Services approved an extraordinary dividend of $44 million to Trupanion from American Pet Insurance Company, and the Board authorized repurchases of up to an aggregate of $100.0 million of common stock with no expiration date. The release provided no forward financial guidance, making enrollment, revenue growth, profitability, cash flow and repurchase execution the disclosed items to monitor next.
Management, verbatim
We continue to execute on the priorities that matter most by growing margin, improving the economics of new enrollments, and investing our capital with discipline.
Margi Tooth, Chief Executive Officer and President of Trupanion
Not in the filing
stated, not guessed- Forward financial guidance
- Previous-period outlook for comparison
- Gross profit and gross margin
- Operating income or loss and operating margin
- Operating expenses
- Income tax expense and tax rate
- Debt balance
- Capital expenditures
- Prior-quarter comparisons for reported metrics
- Complete condensed consolidated statements of operations beyond the subscription business revenue line shown in the provided filing text
- Segment revenue for the other business segment
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
This SEC 8-K (Item 2.02) reports Trupanion’s Q2 2026 financial results and includes capital allocation updates.
Ticker impact
Trupanion reported Q2 2026 results with revenue up 11% YoY, adjusted EBITDA up to $19.8M, and authorized a $100M share repurchase program.
Likely supportive for the stock, with upside bias if investors view margin and cash flow improvement as durable; repurchase authorization may add a floor.
The release includes multiple current-period financial metrics (revenue, net income, adjusted EBITDA, operating and free cash flow) and a new board action (up to $100M buyback) plus an extraordinary dividend approval, all of which are actionable for traders repricing near-term fundamentals.
Market effects
Provides a read-through on profitability and cash generation for pet insurance subscription models, potentially influencing sentiment toward similar insurers.
Primarily US-focused equity sentiment for Nasdaq-listed specialty insurers.
Limited direct global impact beyond investor perception of the specialty pet insurance business model.
Counterpoint
Enrolled pets declined 2% YoY in Q2, which could indicate growth headwinds that may offset margin/cash flow gains.
Key entities
- public_companyTrupanion, Inc.
Nasdaq-listed pet medical insurance provider reporting Q2 2026 results and authorizing up to $100M in share repurchases.
- subsidiaryAmerican Pet Insurance Company
Wholly-owned subsidiary referenced as the recipient of an extraordinary dividend approved by the New York Department of Financial Services.
- regulatorNew York Department of Financial Services
Approved an extraordinary dividend of $44M to be paid to Trupanion in July 2026.
